| Michael Renato Greene, MD,MS | |
|
1 Medical Center Dr, Lebanon, NH 03756-1000 | |
| (603) 650-5000 | |
| Not Available |
| Full Name | Michael Renato Greene |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811099013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 12701 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Renato Greene, MD,MS 196 Bank Street Ext, Lebanon, NH 03766-1173 Ph: (603) 650-4628 | Michael Renato Greene, MD,MS 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 650-5000 |
News Archive
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
North Carolina Gov. Bev Perdue today announced that MCNC has applied to receive $28.1 million in broadband recovery funding through the American Recovery and Reinvestment Act (ARRA) to support fiber acquisition for the North Carolina Research and Education Network (NCREN) in North Carolina.
The Family Health Network, a nonprofit health plan serving Medicaid recipients, has seen its network of providers double over the last three years, from 2,078 primary-care physicians, specialists, hospitals and clinics in 2010 to 4,299 at the close of 2013.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.
Lawmakers continue to be at odds over how to pay for the repeal of this provision, which was originally included in the overhaul as a means to raise revenue to pay for it. The House's offset, for instance, would recoup advance tax subsidies given to lower- and middle-income people to buy insurance if their incomes exceed a certain threshold during the same calendar year.
› Verified 2 days ago
Elias Loukas, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Section Of Hospital Medicine, Lebanon, NH 03756 Phone: 603-650-8380 | |
Dr. Michael W Winter, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Gastroenterology, Lebanon, NH 03756 Phone: 603-650-5261 | |
Hannah Elizabeth Foote Bensimhon, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Victoria Forbes, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5516 | |
Zanira Fazal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18 Old Etna Rd, Lebanon, NH 03766 Phone: 603-650-4000 | |
Susan Si-yao Wang, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth-hitchcock Medical Ctr, Department Of Medicine, Lebanon, NH 03756 Phone: 603-650-9480 | |
Mark Edward Splaine, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc Section Of General Internal Medicine, Lebanon, NH 03756 Phone: 603-653-9500 |